GHRP-2

GHRP-2 Product Description — Research Use Only

GHRP-2, also known as Growth Hormone-Releasing Peptide-2 or Pralmorelin, is a synthetic research peptide studied for its role as a growth hormone secretagogue. It is commonly researched for growth hormone signaling, pituitary response, ghrelin-receptor activity, IGF-1 pathway research, appetite signaling, and metabolic function.

Research on GHRP-2 has most commonly focused on growth hormone release, pituitary signaling, GHSR/ghrelin-receptor activity, IGF-1-related pathways, appetite response, energy balance, and body-composition research. Published literature describes Pralmorelin/GHRP-2 as a synthetic growth hormone-releasing peptide that mimics ghrelin-related signaling and may play roles in GH release, food-intake regulation, bone and muscle growth pathways, and recovery-related research.

GHRP-2 is commonly studied for:

• Growth hormone signaling — how the pituitary releases growth hormone

• Pituitary response — how the pituitary reacts to GH-releasing signals

• Ghrelin-receptor activity — how GHRP-2 interacts with appetite and GH-related receptor pathways

• IGF-1 pathways — how GH signaling may influence IGF-1-related activity

• Appetite signaling — how hunger and food-intake pathways are regulated

• Metabolic research — how energy use and fuel balance are studied

• Body-composition research — markers related to lean mass, fat mass, and energy balance

GHRP-2 is commonly studied because it acts as a growth hormone secretagogue, meaning it is researched for its ability to stimulate GH release rather than supply GH directly. Scientific literature reports that GHRP-2 can stimulate GH secretion through pituitary and hypothalamic pathways, and separate research has investigated its effects on food-intake signaling in relation to ghrelin-like activity.

For research use only. Not for human consumption, medical use, diagnostic use, or therapeutic application.